SEC Form 3 · accession 0001179110-15-009756
Esperion Therapeutics, Inc. · ESPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Braunstein
Director
Period of report
Jun 15, 2015
Accepted (ET)
Jun 15, 2015 · 9:03 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434868
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 52 | D |
Table II — derivative securities
No Table II lines on this filing.